Deutsche Bank réitère sa recommandation d’achat sur Eli Lilly avec la croissance des GLP-1

Investing.com – Deutsche Bank a réitéré sa recommandation d’achat et son objectif de cours de 1.285,00$ sur l’action Eli Lilly (NYSE:LLY), citant les données de prescription des médicaments GLP-1. Le …

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
690